Electronic Health Record Reminder Effect on Hepatitis C Antibody Screening

Article Figures & Data

Table 1.

Demographic Information for Patients Who Had a Hepatitis C Screening Test during Study Period, 2013–2016 (n = 7235)

	Study Population	Period 12013–2014	Period 22015–2016	P-Value
Number of hepatitis C screening tests	7235	733	6502
Age, years, mean (SD)	61.86 (5.61)	61.94 (5.59)	61.85 (5.62)	.685
Male (%)	2851 (39.4)	241 (32.9)	2610 (40.1)	<.001
Race (%)				<.001
American Indian or Alaska Native	27 (0.4)	4 (0.6)	23 (0.4)
Asian	411 (5.9)	14 (2.0)	397 (6.4)
Black or African American	1436 (20.7)	234 (33.8)	1202 (19.3)
White or Caucasian	4695 (67.7)	429 (61.9)	4266 (68.4)
Other	362 (5.2)	12 (1.7)	350 (5.6)

Table 2.

Overall Results of Screening Hepatitis C Antibody Tests during the 4-Year Study Period, 2013–2016, and by Demographic Groups

	Overall	Negative (%)	Positive (%)	P-Value
N	7231	7055 (97.6)	176 (2.4)
Period 1 (%)	733 (10.1)	690 (94.1)	43 (5.9)	<.001
Period 2 (%)	6498 (89.9)	6365 (98.0)	133 (2.0)	<.001
Age, years, Mean (SD)	62.17 (5.62)	62.13 (5.63)	63.76 (5.10)	<.001
Male (%)	2849 (39.4)	2742 (96.2)	107 (3.8)	<.001
Female (%)	4382 (60.6)	4313 (98.4)	69 (1.6)	<.001
Race (%)				<.001
American Indian or Alaska Native	27 (0.4)	25 (92.6)	2 (7.4)
Asian	411 (5.7)	407 (99.0)	4 (0.9)
Black or African American	1435 (20.7)	1370 (95.5)	65 (4.5)
White or Caucasian	4692 (67.7)	4597 (98.0)	95 (2.0)
Other	362 (5.0)	362 (100.0)	0 (0.0)